Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cns Pharmaceuticals Inc (NQ: CNSP )

0.2506 -0.0401 (-13.79%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,880,653
Open 0.2830
Bid (Size) 0.2979 (19)
Ask (Size) 0.3000 (28)
Prev. Close 0.2907
Today's Range 0.2400 - 0.2830
52wk Range 0.2400 - 137.50
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Microsoft Office Outage: Microsoft Investigates Applications, Services Issue
A Microsoft Office outage has workers annoyed as its causing problems with them being able to use the company's services. 
Via InvestorPlace

Performance

YTD
-99.58%
-99.58%
1 Month
-79.46%
-79.46%
3 Month
-97.52%
-97.52%
6 Month
-98.08%
-98.08%
1 Year
-99.78%
-99.78%

More News

Read More
What's Going On With CNS Pharmaceuticals Stock Tuesday?
Via Benzinga
CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series
Via ACCESSWIRE
Brain Cancer in Kids Could Soon Be Detected by 10-Minute Scan
Via Investor Brand Network
SOUN Stock Alert: SoundHound Expands AI Rollout with Stellantis
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Is CNS Pharmaceuticals (CNSP) Stock Down 69% Today?
Via InvestorPlace
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Inks Exclusive License in ‘Transformational’ Step to Treating GBM
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Dow Jumps 200 Points; Pfizer Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies
Via ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CMO to Present Poster at Upcoming SNO/ASCO CNS Cancer Conference
Via Investor Brand Network
CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference
Via ACCESSWIRE
Study Uncovers Ancient Egyptian Attempts to Surgically Remove Brain Cancer
Via Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Exec to Present at Upcoming Virtual Investor Closing Bell Series
Via Investor Brand Network
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Research Identifies How Glioblastoma Develops Resistance to Immunotherapy
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enters Securities Purchase Agreements Worth Estimated $1.98M
Via Investor Brand Network
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
CNS Pharmaceuticals Stock Was Volatile Wednesday: What You Need To Know
Via Benzinga
CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
Via ACCESSWIRE
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Pricing of Registered Direct, Concurrent Private Placement
Via Investor Brand Network
CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.